Trial Profile
A randomised, open-label phase III trial to evaluate the efficacy and safety of Bexarotene (TargretinTM) capsules combined with PUVA, compared to PUVA treatment alone in patients with Mycosis Fungoides
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 30 May 2019
Price :
$35
*
At a glance
- Drugs Bexarotene (Primary) ; Methoxsalen
- Indications Mycosis fungoides
- Focus Therapeutic Use
- 30 May 2019 This trial has been completed in Italy, according to European Clinical Trials Database.
- 30 May 2019 This trial has been completed in Denmark, according to European Clinical Trials Database.
- 07 Nov 2012 New source identified and integrated (European Clinical Trials Database, EudraCT2004-003701-24).